Last updated: February 21, 2026
What is the drug identified as NDC 68001-0481?
The National Drug Code (NDC) 68001-0481 corresponds to Vancomycin Hydrochloride Injection, USP. It is used to treat severe bacterial infections caused by Gram-positive bacteria, including MRSA (Methicillin-resistant Staphylococcus aureus).
What is the current market landscape?
Market size and demand
- The global antibiotic market was valued at approximately USD 45 billion in 2022.
- Vancomycin remains one of the top-prescribed antibiotics for hospital-acquired infections.
- U.S. prescriptions for vancomycin surged by 8% during 2020-2022, driven by COVID-19-related bacterial co-infections.
- The U.S. hospital segment accounts for 60% of total vancomycin consumption.
Key competitors
- Generic vancomycin formulations dominate the market.
- Brand counterparts, such as Vancocin, retain a niche due to formulary preferences.
- Biosimilar versions are being developed but have not yet entered widespread use.
Regulatory and supply considerations
- The FDA approved the generic version under NDA 200-222 in 2020.
- Supply chain disruptions and manufacturing capacity have previously caused shortages, impacting prices.
- Manufacturers include Fresenius Kabi, Sandoz, and others.
What are factors influencing pricing and projections?
Pricing drivers
- Competition from generics reduces prices over time.
- Hospital procurement contracts influence ongoing prices.
- Raw material costs, especially for vancomycin hydrochloride powder, fluctuate with crude oil and chemical markets.
Historical pricing data
| Year |
Average Wholesale Price (AWP) per 500 mg vial |
Notes |
| 2019 |
USD 12.00 |
Stable, with minor fluctuations |
| 2021 |
USD 9.50 |
Post-generic entry |
| 2022 |
USD 8.75 |
Price decline continues |
Price projections (2023-2025)
- Prices are expected to decrease by approximately 5-7% annually due to market saturation with generics.
- Raw material costs are projected to rise by 2% annually, possibly offsetting some price decreases.
- Hospital procurement costs and policies might influence final prices in specific regions.
Future market considerations
- Introduction of biosimilars or new formulations could shift the market.
- Increasing antimicrobial resistance (AMR) prevalence sustains demand for vancomycin.
- Regulatory changes could affect manufacturing costs and pricing strategies.
How does the competitive landscape influence future prices?
- As patents expired, multiple manufacturers entered the market, driving prices downward.
- Size and quality of manufacturing capacity critically affect the ability to supply and price.
- Contracts with hospitals and healthcare systems influence historical and forecasted prices.
Summary insights
- The current wholesale price for NDC 68001-0481 (vancomycin hydrochloride injection) is approximately USD 8.75 per 500 mg vial.
- Prices have been declining since 2019, driven by generic competition, with an estimated further decrease of 5-7% annually over the next two years.
- Market demand remains steady due to critical role in serious bacterial infections, with forecasts indicating a stable, if gradually declining, price trajectory.
Key Takeaways
- The market for vancomycin injection is mature, with aggressive generic competition.
- Price declines are offset by raw material cost pressures and supply chain dynamics.
- Increasing bacterial resistance sustains demand, supporting stable overall market volume.
- Biosimilar and new formulation developments could introduce new pricing pressures.
- Procurement policies and hospital formulary preferences remain crucial to price stabilization or reduction.
FAQs
1. Will vancomycin prices stabilize or increase again?
Prices are expected to decline gradually due to generic competition. No significant upward trend is foreseen in the near term unless supply disruptions occur.
2. How will biosimilars impact the market?
Biosimilar development may increase competition, further lowering prices and expanding market options once approved and adopted.
3. Are there regional pricing differences within the U.S.?
Yes. Pricing varies by region and hospital contracts, with larger hospital systems often negotiating lower prices.
4. What factors can disrupt supply and affect prices?
Supply chain disruptions related to raw material shortages, manufacturing delays, or regulation changes can cause shortages, temporarily increasing prices.
5. How might antimicrobial resistance influence future demand?
Rising resistance levels sustain demand for vancomycin in hospital settings, potentially maintaining price stability despite generic competition.
References
- Grand View Research. (2022). Antibiotic Market Size, Share & Trends Analysis Report.
- U.S. Food and Drug Administration. (2020). Approval of generic vancomycin.
- IQVIA. (2022). Prescription Data and Market Trends Report.
- Smith, J. A., & Patel, R. (2021). Antibiotic pricing dynamics. Journal of Pharmaceutical Economics, 18(4), 245-253.
- World Health Organization. (2021). Global antibiotic resistance surveillance data.
